Translation News and Research

RSS

Phico Therapeutics gets £2.25M Translation Award to develop SASPject PT4 antibiotic for E. coli, K. pneumoniae

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae.

9 Mar 2015

Non-viral gene therapy provides relief for diabetics with constant foot pain

Walking barefoot on sand "felt like walking on glass" for Keith Wenckowski, who has lived with type-one diabetes for more than two decades.

6 Mar 2015

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

Brain scientists map changes in communication between nerve cells in rats

Lights, sound, action: we are constantly learning how to incorporate outside sensations into our reactions in specific situations. In a new study, brain scientists have mapped changes in communication between nerve cells as rats learned to make specific decisions in response to particular sounds. The team then used this map to accurately predict the rats' reactions. These results add to our understanding of how the brain processes sensations and forms memories to inform behavior.

3 Mar 2015

Scientists produce cartilage from embryonic stem cells

Scientists have succeeded in producing cartilage formed from embryonic stem cells that could in future be used to treat the painful joint condition osteoarthritis.

3 Mar 2015

Autism Speaks' affiliate DELSIA announces new funding for clinical trial of cognitive video game

Autism Speaks' not-for-profit affiliate Delivering Scientific Innovation for Autism has announced new funding for clinical testing of a cognitive video game designed to improve executive function skills in children and adolescents with autism.

3 Mar 2015

Novel financing technique may unlock funding for developing 'orphan' drugs to treat rare diseases

A paper published today, "Financing translation: Analysis of the NCATS rare-diseases portfolio" in Science Translational Medicine, demonstrates the potential of a new financing technique to reduce the risk associated with investing in the treatment of new diseases and potentially unlock new levels of funding for developing so-called "orphan" drugs.

28 Feb 2015

MD Anderson awarded more than $22 million in research grants from CPRIT

The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.

21 Feb 2015

Targeted nanomedicines could help prevent heart attacks caused by atherosclerosis

Nanometer-sized "drones" that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks caused by atherosclerosis, according to a study in pre-clinical models by scientists at Brigham and Women's Hospital and Columbia University Medical Center.

19 Feb 2015

Sugar intake and tooth decay: an interview with Professor Nigel Pitts

Globally, dental caries (the technical term for tooth decay) is the most prevalent non-communicable disease, affecting 80% of the global population. Healthy teeth support overall well-being, while dental caries can contribute to high levels of pain and anxiety, as well as leading to other medical problems.

18 Feb 2015

Innophos Holdings' net sales decrease 1% to $194 million in fourth quarter 2014

Innophos Holdings, Inc., a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets, today announced its financial results for the fourth quarter and full year 2014.

18 Feb 2015

Study findings could help scientists better design silicon materials to improve chemotherapy drug delivery

A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.

16 Feb 2015

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.

11 Feb 2015

New type of engineered insulin could improve treatment for diabetes patients

For patients with diabetes, insulin is critical to maintaining good health and normal blood-sugar levels. However, it's not an ideal solution because it can be difficult for patients to determine exactly how much insulin they need to prevent their blood sugar from swinging too high or too low.

11 Feb 2015

New RT-DC technology enables faster and continuous mechanical screening of cells

Cells, like any other material, have mechanical properties that can serve for their characterization. For example, cancer cells are characteristically more deformable than healthy cells.

9 Feb 2015

Decades of progress save countless lives, but biggest research challenges lie ahead

The 2015 Heart and Stroke Foundation Report on the Health of Canadians looks back on 60 years of life-saving, ground-breaking research, revealing astonishing improvements in diagnosis, treatments, and outcomes.

6 Feb 2015

Meditation appears to help preserve the brain's gray matter

Since 1970, life expectancy around the world has risen dramatically, with people living more than 10 years longer. That's the good news.

6 Feb 2015

Recipients of The 2015 Protein Society Awards announced

The Protein Society, the premiere international society dedicated to supporting protein research, announces the winners of The 2015 Protein Society Awards. The awards will be conferred at the 29th Annual Symposium of The Protein Society (July 22-25, 2015, Barcelona, Spain).

5 Feb 2015

Battlefield blood transfusion protocol improves patient outcomes

Working to save the lives of military personnel suffering massive blood loss in the Afghanistan and Iraq wars, United States military trauma surgeons developed a blood transfusion protocol that is employed in most military and civilian hospitals today.

5 Feb 2015

Genomics of papillary thyroid carcinoma (PTC): an interview with Professor Thomas J. Giordano

There are two types of thyroid cells and therefore there are two broad types of thyroid cancer. Medullary carcinoma is derived from parafollicular or C cells, whereas follicular cells give rise to several types of thyroid cancers.

4 Feb 2015

Translation News and Research

Phico Therapeutics gets £2.25M Translation Award to develop SASPject PT4 antibiotic for E. coli, K. pneumoniae

Non-viral gene therapy provides relief for diabetics with constant foot pain

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Brain scientists map changes in communication between nerve cells in rats

Scientists produce cartilage from embryonic stem cells

Autism Speaks' affiliate DELSIA announces new funding for clinical trial of cognitive video game

Novel financing technique may unlock funding for developing 'orphan' drugs to treat rare diseases

MD Anderson awarded more than $22 million in research grants from CPRIT

Targeted nanomedicines could help prevent heart attacks caused by atherosclerosis

Sugar intake and tooth decay: an interview with Professor Nigel Pitts

Innophos Holdings' net sales decrease 1% to $194 million in fourth quarter 2014

Study findings could help scientists better design silicon materials to improve chemotherapy drug delivery

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

New type of engineered insulin could improve treatment for diabetes patients

New RT-DC technology enables faster and continuous mechanical screening of cells

Decades of progress save countless lives, but biggest research challenges lie ahead

Meditation appears to help preserve the brain's gray matter

Recipients of The 2015 Protein Society Awards announced

Battlefield blood transfusion protocol improves patient outcomes

Genomics of papillary thyroid carcinoma (PTC): an interview with Professor Thomas J. Giordano

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News